Eric Nguyen-Khac

Eric Nguyen-Khac

Auto-generated profile, based on publicly available information

Eric Nguyen-Khac

GRAP INSERM U1247, Curs Université Picardie Jules Verne Amiens France

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ENEric Nguyen-Khac
Eric Nguyen-Khac
TTThierry Thevenot
Thierry Thevenot
MPMarie-Astrid Piquet
Marie-Astrid Piquet
SBSaïd Benferhat
Saïd Benferhat
OGOdile Goria
Odile Goria
JDJean-Louis Dupas
Jean-Louis Dupas
Mortality among patients with severe acute alcoholic hepatitis is high, even among those treated with glucocorticoids. We investigated whether combination therapy with glucocorticoids plus N-acetylcysteine would improve survival.

1 September 2018 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
ENEric Nguyen-Khac
Eric Nguyen-Khac
MTMaja Thiele
Maja Thiele
CVCosmin Voican
Cosmin Voican
PNPierre Nahon
Pierre Nahon
CMChristophe Moreno
Christophe Moreno
MDMomar Diouf
Momar Diouf

31 May 2013 in Hepatology
Verified
Journal Article
Open access
PDF file
OMOriol Morales-Ibanez
Oriol Morales-Ibanez
MGMarlene Dominguez Garcia
Marlene Dominguez Garcia
Sung Hwan KiSung Hwan Ki
Sung Hwan Ki
MMMiguel Marcos
Miguel Marcos
FCFELIPE JAVIER CHAVES
FELIPE JAVIER CHAVES
RBRamón Bataller
Ramón Bataller
We identified, in the transcriptome analysis of patients with alcoholic hepatitis (AH), osteopontin (OPN) as one of the most up-regulated genes. Here, we used a translational approach to investigate its pathogenic role. OPN hepatic gene expression was quantified in patients with AH and other liver diseases. OPN protein expression and processing were assessed by immmunohistochemistry, western blotting and enzyme-linked immunosorbent assay. OPN gene polymorphisms were evaluated in patients with alcoholic liver disease. The role of OPN was evaluated in OPN−/− mice with alcohol-induced liver injury. OPN biological actions were studied in human hepatic stellate cells (HSCs) and in precision-cut liver slices. Hepatic expression and serum levels of OPN were markedly increased in AH, compared to normal livers and other types of chronic liver diseases, and correlated with short-term survival. Serum levels of OPN also correlated with hepatic expression and disease severity. OPN was mainly expressed in areas with inflammation and fibrosis. Two proteases that process OPN (thrombin and matrix metalloproteinase 7) and cleaved OPN were increased in livers with AH. Patients with AH had a tendency of a lower frequency of the CC genotype of the +1239C single-nucleotide polymorphism of the OPN gene, compared to patients with alcohol abuse without liver disease. Importantly, OPN−/− mice were protected against alcohol-induced liver injury and showed decreased expression of inflammatory cytokines. Finally, OPN was induced by lipopolysaccharide and stimulated inflammatory actions in HSCs. Conclusion: Human and experimental data suggest a role for OPN in the pathogenesis of AH. Further studies should evaluate OPN as a potential therapeutic target. (Hepatology 2013;58:1742–1756)

1 December 2006 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
ENEric Nguyen-Khac
Eric Nguyen-Khac
DCDominique Capron
Dominique Capron
Methods for diagnosing hepatic fibrosis have progressed significantly over the last few years--notably with the appearance of minimally invasive biological tests (which avoid the need for liver needle biopsy but nevertheless require a blood sample). Hepatic ultrasonic transient elastography (Fibroscan) is a new diagnostic method for hepatic fibrosis: it is totally noninvasive and gives an immediate result. Here, we review the currently available data on the use of the Fibroscan. Today's main field of application is chronic, viral hepatitis C, with areas under the receiver operation characteristic curve of 0.79-0.83, 0.90-0.91 and 0.91-0.97 for the diagnosis of F2, F3 and F4 fibrosis (defined according to the Metavir classification system), respectively. Furthermore, the Fibroscan enables the noninvasive diagnosis of cirrhosis (regardless of the latter's aetiology), with positive and negative predictive values of 70-95% and 77-95%, respectively. Chronic viral hepatitis B, HIV-hepatitis C virus and HIV-hepatitis B virus coinfections, alcohol-related liver diseases and intrahepatic cholestatic diseases are the device's other main fields of application in hepatology. Today, the Fibroscan is a reliable alternative for the noninvasive diagnosis of hepatic fibrosis. Various diagnostic strategies and performing cost/benefit analyses are now necessary, to assess fully the value of hepatic elastography relative to biological tests for hepatic fibrosis.

4 July 2008 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
ENE. Nguyen‐Khac
E. Nguyen‐Khac
JCJ.‐F. Cadranel
J.‐F. Cadranel
TTT. Thevenot
T. Thevenot
JNJ.‐B. Nousbaum
J.‐B. Nousbaum

23 June 2010 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
ENEric Nguyen‐Khac
Eric Nguyen‐Khac
PSPierre Saint‐Leger
Pierre Saint‐Leger
BTBlaise Tramier
Blaise Tramier
HCHugues Coevoet
Hugues Coevoet
DCDominique Capron
Dominique Capron
JDJean‐Louis Dupas
Jean‐Louis Dupas